Pyridam Farma Tbk
Hub Segmentasi: Analisis Fundamental Umum (General Hub)
Tingkat pengembalian modal yang diinvestasikan. Nilai > 12% menunjukkan alokasi modal...
Mendeteksi kualitas laba bersih. Rasio di luar rentang -10% s/d 10% mengindikasikan l...
Rasio total utang terhadap modal ekuitas bersih.
Diagnosis Kesimpulan Sektor
Kinerja fundamental stabil, namun perhatikan tingkat margin laba bersih operasional dan rasio utang ekuitas.
Emiten teratas dalam sektor Healthcare
PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care and beauty products; medical support products; and other consumer health products in the form of syrups, tablets, and capsules; sterile and injection; and sanitizers and antiseptics. In addition, it offers antiseptic solutions, betadine antiseptic skin cleansers, Betadine Vaginal Douche, Cold defense nasal and throat sprays, feminine hygiene, Guardix SG, Mouthwash and Gargle, Salep antiseptic products. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.
Beginner Insight:Understanding the "Architecture" helps you verify the company's physical scale and legitimacy. A global workforce usually indicates a mature, institutional player.